Davidson Kempner Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11,640
Closed -$3.14M 630
2021
Q4
$3.14M Buy
+11,640
New +$2.88M 0.05% 291
2020
Q1
Sell
-44,651
Closed -$6.49M 179
2019
Q4
$6.49M Buy
44,651
+28,169
+171% +$4.07M 0.15% 106
2019
Q3
$2.38M Buy
+16,482
New +$2.41M 0.05% 117

Other funds holding LH

Davidson Kempner Capital Management's LH Position: Q1 2022 in Review

Davidson Kempner Capital Management sold out of Labcorp (LH) in Q1 2022, closing a stake of 11,640 shares — an estimated $3.14M sold.

Davidson Kempner Capital Management first reported a position in LH in Q3 2019 and held it in 3 quarters. The position peaked at $6.49M in Q4 2019. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • Davidson Kempner Capital Management reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 11,640 Labcorp shares in Q1 2022, an estimated $3.14M.
  • Davidson Kempner Capital Management first reported a position in Labcorp in Q3 2019 and held it in 3 quarters.
  • Davidson Kempner Capital Management's Labcorp position peaked at $6.49M in Q4 2019.
  • 1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2022, filed 16 May 2022.